Big pharmacies and public health clinics in Georgia are not yet giving this year’s COVID-19 booster shots, or are putting new restrictions in place, amid vaccine uncertainty under Department of Health ...

Nasus management will be available for one-on-one meetings during the conference. Interested investors should contact their respective representative at the sponsoring institutions to request meetings ...

TEL AVIV, Israel, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Nasus Pharma Ltd. (NYSE: NSRX) (“Nasus Pharma” or the “Company”), a clinical-stage pharmaceutical company focused on the development of innovative ...

Who's at the top of the Wild Rift tier list? While all champions are viable in Riot's hit mobile MOBA, there are some that are simply a cut above the rest. We're here to help you pick which champion ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Nasus Pharma Ltd. ( (NSRX)) has shared an ...

TEL AVIV, Israel, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Nasus Pharma Ltd. (NYSE: NSRX) (“Nasus Pharma” or the “Company”), a clinical-stage pharmaceutical company focused on the development of innovative ...

The Tel Aviv-based company develops powder-based Intranasal specialized treatments. Israeli company Nasus Pharma (NYSE: NSRX), which develops powder-based Intranasal specialized treatments, has ...

Nasus Pharma has granted the underwriters an option to purchase up to an additional 187,500 ordinary shares at the initial public offering price within 45 days from the date of the final prospectus to ...

Nasus Pharma Ltd. (NYSE American: NSRX) priced its initial public offering of 1,250,000 ordinary shares at $8.00 per share, generating gross proceeds of $10 million before deducting underwriting fees ...

The recent League of Legends patch brought changes to the Ranked meta, some champions start climbing up the ranks, whilst others become bad options. LoL 25.14 delivered nerfs, buffs, and adjustments.

Nasus Pharma Ltd (NYSE:NSRX) has filed to raise $11 million in an IPO of its ordinary shares, according to SEC F-1 registration information. The company is developing an intranasal powder spray for ...